Novo-Nordisk stock heads into the open after a 7.7 percent drop
Published on 09/22/2026 at 08:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Novo-Nordisk stock closed 7.7 percent lower on Nasdaq Copenhagen on September 21, 2026, after the company presented long-term targets at its Capital Markets Day. The STOXX 600 rose 0.9 percent in the same session, leaving the stock 8.6 percentage points behind the regional benchmark.
September 21, 2026 in numbers
Novo Nordisk A/S (ISIN DK0062498333) fell as investors questioned whether its pipeline and dealmaking strategy could offset future patent expiries. As Reuters reported on September 21, 2026, executives faced questions about pricing assumptions and future premium pricing.
The company said at the London event that it aims to launch more than five blockbuster drugs by 2030 and generate more than DKK 150 billion in pipeline sales by 2035. CNBC reported that the Copenhagen-listed shares recorded their worst session since February.
Capital Markets Day follows today
Novo Nordisk held its Capital Markets Day in London on September 21, 2026, from 10:00 to 16:30 CET, according to the company events calendar. The market therefore enters September 22, 2026 with the new pipeline and sales targets as the latest company-specific information.
